Abstract
Cancer is a disease of the genome. Most tumors harbor a constellation of structural genomic alterations that may dictate their clinical behavior and treatment response. Whereas elucidating the nature and importance of these genomic alterations has been the goal of cancer biologists for several decades, ongoing global genome characterization efforts are revolutionizing both tumor biology and the optimal paradigm for cancer treatment at an unprecedented scope. The pace of advance has been empowered, in large part, through disruptive technological innovations that render complete cancer genome characterization feasible on a large scale. This article highlights cardinal biologic and clinical insights gleaned from systematic cancer genome characterization. We also discuss how the convergence of cancer genome biology, technology, and targeted therapeutics articulates a cohesive framework for the advent of personalized cancer medicine.
Keywords
GenomePersonalized medicineComputational biologyCancerDiseaseScope (computer science)GenomicsPrecision medicinePaceHuman genomeMedicineBiologyBioinformaticsGeneticsGeneComputer sciencePathology
Affiliated Institutions
Related Publications
The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine
The Human Gene Mutation Database (HGMD®) is a comprehensive collection of germline mutations in nuclear genes that underlie, or are associated with, human inherited disease. By ...
Genetic alterations in breast cancer
Abstract The etiology of breast cancer involves a complex interplay of various factors, including genetic alterations. Many studies have been devoted to the identification and c...
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
Somatic mutations in the TP53 gene are one of the most frequent alterations in human cancers, and germline mutations are the underlying cause of Li-Fraumeni syndrome, which pred...
The Human Genome Project
The recently initiated human genome project is a large international effort to elucidate the genetic architecture of the genomes of man and several model organisms. The initial ...
Heterogeneity in Breast Cancer and the Problem of Relevance of Findings
Many attempts are made to identify critical genetic events responsible for the development and progression of breast cancer. There is increasing evidence that breast cancer is a...
Publication Info
- Year
- 2010
- Type
- review
- Volume
- 28
- Issue
- 35
- Pages
- 5219-5228
- Citations
- 225
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
225
OpenAlex
Cite This
Laura E. MacConaill,
Levi A. Garraway
(2010).
Clinical Implications of the Cancer Genome.
Journal of Clinical Oncology
, 28
(35)
, 5219-5228.
https://doi.org/10.1200/jco.2009.27.4944
Identifiers
- DOI
- 10.1200/jco.2009.27.4944